Most Read Articles
Roshini Claire Anthony, 13 Aug 2018

A genotype-guided approach to warfarin dosing may result in fewer dose adjustments in Asian patients, according to a study from Singapore.

Rachel Soon, 6 days ago

At the recent Malaysian Community Pharmacy Business Forum (MyCPBF), a discussion forum was held on the subject of “Transcending Primary Healthcare Services: The Future of Specialized Pharmacy Services and Pharmacy Specialization”.

19 Jul 2018
Nonsteroidal anti-inflammatory drugs (NSAIDs) appear to increase the risk of major bleeding, stroke or systemic embolism, and hospitalization among patients with atrial fibrillation (AF), suggest the results of the RE-LY* trial. Moreover, there is no difference in the safety and efficacy of dabigatran etexilate (DE) 150 and 110 mg twice daily relative to warfarin.
09 Dec 2017
Hydrochlorothiazide (HCTZ) appears to significantly increase the risks of nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC), a recent study has shown.

Multidisciplinary cardiac rehab programme improves CHD risk factors, patient's knowledge

Pearl Toh
30 Oct 2017

A multidisciplinary inpatient cardiac rehabilitation programme (CRP) helps reduce risk factors for coronary heart disease (CHD) and improves proper prescription of evidence-based medication as well as patient's knowledge about the disease, according to a study presented at SPCRS 2017.

Noting that CRP is constantly underutilized despite its well-established benefits, a multidisciplinary CRP involving a joint collaboration between the Department of Anaesthesia and Intensive Care, Department of Medicine and Geriatrics, and Department of Physiotherapy was implemented in Cardiac Care Unit (CCU) of Pok Oi Hospital in Hong Kong. 

The study included 310 patients (mean age 60.4 years,85.5 percent males, 75.5 percent had ACS*, 94.5 percent had PCI**) admitted to CCU with CHD after stabilization. Risk factors for CHD were identified by attending cardiologists followed by education programme about CHD and control of risk factors offered by nurses, during which the patient's knowledge on CHD was assessed before and after attending CRP using a standardize questionnaire. Selected patients who had undergone revascularization were referred to physiotherapist to facilitate early mobilization. Blood test was performed at admission and during follow-up at outpatient clinics.  

After a mean follow-up of 59 days, significant improvements from baseline were seen in various risk factors as assessed through blood sampling, including total cholesterol (C), LDL-C, HDL-C, and triglyceride (p<0.001 for all, except triglyceride, p=0.001). Fasting glucose (-12.5 percent; p<0.001) and HbA1c (-3.8 percent; p=0.018) were also significantly improved compared with baseline. [SPCRS 2017, abstract N-37]  

In addition, patient's knowledge improved by 14.3 percent after CRP, as indicated by increase in their questionnaire scores (12.14 vs 13.8; p<0.001). 

Compared with prescription at study recruitment, there was significant improvement in the percentage of prescription of evidence-based medications on discharge, including ACEIs*** (51.6 percent vs 71.3 percent), beta-blockers (51.0 percent vs 65.8 percent), and statins (97.7 percent vs 98.7 percent; all p<0.001).

“The multidisciplinary inpatient CRP was effective in reducing risk factors, prescription percentage of evidence-based medication and enhanced patient's knowledge,” concluded the authors.   

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 13 Aug 2018

A genotype-guided approach to warfarin dosing may result in fewer dose adjustments in Asian patients, according to a study from Singapore.

Rachel Soon, 6 days ago

At the recent Malaysian Community Pharmacy Business Forum (MyCPBF), a discussion forum was held on the subject of “Transcending Primary Healthcare Services: The Future of Specialized Pharmacy Services and Pharmacy Specialization”.

19 Jul 2018
Nonsteroidal anti-inflammatory drugs (NSAIDs) appear to increase the risk of major bleeding, stroke or systemic embolism, and hospitalization among patients with atrial fibrillation (AF), suggest the results of the RE-LY* trial. Moreover, there is no difference in the safety and efficacy of dabigatran etexilate (DE) 150 and 110 mg twice daily relative to warfarin.
09 Dec 2017
Hydrochlorothiazide (HCTZ) appears to significantly increase the risks of nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC), a recent study has shown.